Search Results 1281-1290 of 18424 for Immunode

1. Clinical Trials - Tesevatinib in Subjects With ADPKD

   Known to be positive for the human immunodeficiency virus or hepatitis B or C, as indicated by a positive test at screening. Known to be immunocompromised ...

2. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

   Clinically significant hepatitis at Screening, or hepatitis C antibody positive, hepatitis B surface antigen positive, or human immunodeficiency virus (HIV) ...

3. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   ... immunodeficiency virus (HIV) infection and bleeding disorders. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

4. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

   Human immunodeficiency virus (HIV) or hepatitis B or C; Prior treatment with cluster of differentiation (CD) 137 agonist, anti-programmed death (PD) 1, or ...

5. Drug allergy - Doctors and departments - Mayo Clinic

   Rank, M.D.. Internist; Pediatrician; Allergist-Immunologist. Phoenix, AZ. Areas of focus: Immunotherapy, Eosinophilic esophagitis, Primary immunodeficiency, ...

6. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   NOTE: subjects with well-controlled human immunodeficiency virus (HIV) infection and CD4 count > 300 cells/mcL may be enrolled, provided that all other protocol ...

7. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   ... immunodeficiency virus (HIV) antibody results, or acquired immunodeficiency syndrome (AIDS) related illness. Note: Subjects with a sustained viral response ...

8. Mayo Clinic Laboratories.

9. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

   A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. J Mol Diagn. 2017 Sep; 19(5):755-765. View PubMed; Nambot S, Gavrilov D ...

10. Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) - Mayo Clinic

    * Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at time of registration and have ...